title: Proliferative activity, angiogenesis and nuclear morphometry in renal cell carcinoma.
abstract: BACKGROUND
  Prognostic parameters other than tumor stage and grade are essential for renal cell carcinoma (RCC) patients. This study was undertaken to determine the usefulness of cellular proliferation, angiogenesis and nuclear morphometry in predicting the biological aggressiveness of RCC.
  
  
  METHODS
  Surgical specimens of 70 patients with RCC were investigated by conventional histology, Ki-67 immunostaining and stereological assessment of angiogenesis and mean nuclear volume.
  
  
  RESULTS
  There was no difference in disease-specific survival with respect to sex, age and histopathological type (except sarcomatoid and other types). The survival was significantly lower and the chance of metastases was higher in the group with higher proliferative activity (P=0.007). There was no relation between angiogenesis, mean nuclear volume, stage and survival. There was a significant relation between both Fuhrman and WHO grades, tumor stage and survival. Histopathological type, grade, angiogenesis and mean nuclear volume failed to predict recurrences and/or metastases. In multivariate analysis, only TNM stage and proliferative activity were found to be independent prognostic factors.
  
  
  CONCLUSIONS
  In addition to tumor grade and stage, proliferative activity of a given RCC may have the potential to identify patients with an impaired prognosis.
authors.affiliation: Departments of Urology and Pathology, Dokuz Eylul University, School of Medicine, Izmir, Turkey. ziya.kirkali@deu.edu.tr
authors.forename: Z
authors.initials: Z
authors.lastname: Kirkali
authors.forename: K
authors.initials: K
authors.lastname: Yorukoglu
authors.forename: E
authors.initials: E
authors.lastname: Ozkara
authors.forename: H
authors.initials: H
authors.lastname: Kazimoglu
authors.forename: U
authors.initials: U
authors.lastname: Mungan
mesh_terms: D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000473:pathology* / Q000628:therapy; D002467:Cell Nucleus / Q000648:ultrastructure; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009389:Neovascularization, Pathologic
chemical_list: D019394:Ki-67 Antigen